BRIAN SIMMONS: Open Payments
NPI 1225508096 · EAGLE MOUNTAIN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 17 payments from 11 companies in 2025. Trend: 2023 $493 · 2024 $343 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| ABBVIE INC. | 3 | $51 |
| PFIZER INC. | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Corium, LLC | 2 | $10 |
Products named: AIRSUPRA, PAXLOVID, QULIPTA, Auvelity, CAPLYTA, VRAYLAR, Rybelsus, Veozah.
Industry payments across UT — which companies pay providers there.
